SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing a sharp sell-off driven by a confluence of negative sentiment, including a federal jury finding that Elon Musk defrauded Twitter shareholders and concerns regarding broader macroeconomic instability. The community is deeply divided, with bears pointing to falling delivery numbers and operational scrutiny as evidence of a structural decline, while loyal bulls continue to highlight upcoming projects like TeraFab and the potential for a rebound as reasons to maintain their positions.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors capitalize on its recent NYSE listing, which provides rare public market access to high-profile private AI and tech companies like Anthropic, OpenAI, and SpaceX. While the community is actively debating the significant premium over the fund's net asset value and the impact of a six-month lockup on available float, many are focused on the stock's high volatility and potential for momentum-driven price swings.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is currently trending due to a major data breach involving approximately 33 million accounts, sparking intense regulatory scrutiny, a nationwide boycott in South Korea, and a significant leadership shake-up. Investors are actively debating the potential for long-term recovery against the backdrop of mounting legal liabilities, government investigations, and consumer backlash that threatens to disrupt the company's core market.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility and downward pressure as investors weigh recent acquisition activity against broader macroeconomic headwinds, including geopolitical tensions and fluctuating construction market sentiment. Despite the bearish pressure, the community remains actively divided, with many long-term shareholders continuing to express confidence in CEO Brad Jacobs' consolidation strategy while others closely monitor for the next M&A catalyst or integration updates.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is trending as the market highlights the intersection of AI and decentralized infrastructure, with community discussions heavily focused on the significance of the upcoming halving event. Investors are actively debating the long-term potential of the Bittensor network's subnet model, positioning it as a foundational layer for sovereign AI.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is generating significant buzz as investors anticipate upcoming fourth-quarter earnings and critical updates regarding the clinical development of its pipeline candidate, aritinercept. The community is actively debating the company's long-term valuation, with many shareholders expressing frustration over management's communication style while simultaneously monitoring potential M&A activity within the broader biotech sector.

iShares Trust - iShares iBoxx USD Investment Grade Corporate Bond ETF

iShares iBoxx USD Investment Grade Corporate Bond ETF

The iShares iBoxx USD Investment Grade Corporate Bond ETF ($LQD) is trending as investors monitor escalating credit risks and the potential for a broad debt default wave in a rising rate environment. The community is heavily focused on the breakdown in investment-grade and high-yield bond prices, with many participants using options to hedge against further downside volatility.

Netskope, Inc. engages in the provision of cloud based security solutions. It offers business developing analytics for visibility, policy enforcement and other cloud solutions. Its products include Netskope one SASE, Netskope one SSE, cloud access security broker, next generation secure web gateway, private access, cloud firewall, SD-WAN and skopeAI. The company was founded by Sanjay Beri, Lebin Cheng, Ravishankar Ithal, and Krishna Narayanaswamy in October 2012 and is headquartered in Santa Clara, CA.

Netskope Inc. - Ordinary Shares - Class A

Netskope is attracting significant investor interest as it trades near its IPO price, with the community actively discussing potential undervaluation, strong institutional buying, and the company's critical role in AI-native cybersecurity. Despite recent price volatility and concerns surrounding lock-up expiration, many traders view the stock as a long-term acquisition target, emphasizing its solid fundamentals and growing market share in the SASE sector.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy Corp ($VLO) is attracting significant attention as investors weigh the stock's long-term refining dominance and renewable diesel growth potential against ongoing market volatility. Community discourse remains divided, with traders closely monitoring the impact of shifting geopolitical landscapes on refining margins and whether the stock's recent price action signals a structural breakout or a consolidation phase.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

The community is actively trading the high volatility of $MSTZ, with many traders sharing their success in utilizing it as a tactical hedge or scalp against the price action of $MSTR and broader crypto market movements. Discussions highlight a split between those treating the asset as a quick day-trading instrument to capitalize on intraday pullbacks and those holding longer-term positions, while others debate the inherent risks of leveraged products in a volatile sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of cancer therapy developer Kronos Bio Inc. (<a class="mention" data-mention="$KRON" data-symbol-id="KRON" href="https://stocktwits.com/symbol/KRON" target="_blank">$KRON</a>) surged over 13% to hit their highest level since Nov. 6, with trading volume spiking more than six times the daily average.&nbsp;The jump came after the company announced a drastic workforce reduction of approximately 83% by the end of the year.&nbsp;The company said this move is part of a broader strategy to implement cost-cutting measures while exploring potential business combinations and/or divesting its remaining preclinical assets to maximize shareholder value.Also, Kronos Bio revealed a leadership change: Deborah Knobelman will be appointed President and Interim CEO, effective Dec. 3.&nbsp;Knobelman will take over from Norbert Bischofberger, who has been with the company since 2018 and will step down to remain on the Board of Directors and serve as an adviser.<figure class="image"><a href="https://stocktwits.com/symbol/KRON"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_27_at_8_56_24_PM_7fc5adb6e1.png" alt="Screenshot 2024-11-27 at 8.56.24 PM.png" width="1318" height="318"></a><figcaption>KRON sentiment and message volume on Nov 27 as of 10:35 am ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits climbed higher within the ‘extremely bullish’ territory, accompanied by a significant increase in message volume.&nbsp;<stembedurl>https://stocktwits.com/youspeaktome/message/594265060</stembedurl>The workforce reduction follows an earlier 21% cut announced in March, with Kronos Bio estimating a $3.7 million charge related to the layoffs.&nbsp;As of March 2024, the company reportedly had 62 full-time employees and one part-time employee.Over a week ago, Piper Sandler had lowered its price target on Kronos Bio from $6 to $1 after the company halted development of its lead candidate, istisociclib, due to some adverse events in ovarian cancer patients.&nbsp;Kronos Bio’s stock has fallen around 31% year-to-date, but the latest developments appears to have rekindled optimism among retail investors.For updates and corrections email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/crvo-stock-surges-on-fda-nod-for-ftd-treatment/cJI0xvNRWB">CervoMed Stock Surges On FDA Orphan Drug Nod For FTD Treatment: Retail Optimism Rekindled</a>

Kronos Bio’s stock has fallen around 31% year-to-date, but the latest developments appears to have rekindled optimism.

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up

The company said this move is part of a broader strategy to implement cost-cutting measures.

Equity

The company said this move is part of a broader strategy to implement cost-cutting measures.


Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.33	--	--	N/A
Q4 '24	-$0.29	-$0.43	-47.11%	MISSED
Q3 '24	-$0.28	-$0.23	17.12%	BEAT
Q2 '24	-$0.34	-$0.27	19.40%	BEAT
Q1 '24	-$0.42	-$0.50	-18.34%	MISSED

KRON
Kronos Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '24

Historical Earnings

Latest KRON News

KRONKronos Bio Inc